BioCryst Presents New Real-world Data Showing Rapid, Substan

23.02.2024 - RESEARCH TRIANGLE PARK, N.C., Feb. 23, 2024 (GLOBE NEWSWIRE) - BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced new analyses of real-world use of oral, once-daily ORLADEYO (berotralstat) that showed patients who initiated ORLADEYO ... Seite 1

Related Keywords

United States , Bryan Arnold , Jonathan Bernstein , Bernstein Clinical Research Center , University Of Cincinnati , Bernstein Allergy Group , Bernstein Clinical Research , Rate Reduction After Beginning , Multiple Patient , Biocryst Pharmaceuticals Chart , Iocryst Pharmaceuticals Kurs , Iocryst Pharmaceuticals Aktie ,